Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure G Bröms, F Granath, M Linder, O Stephansson, M Elmberg, H Kieler Inflammatory bowel diseases 20 (6), 1091-1098, 2014 | 236 | 2014 |
Opioid prescribing after surgery in the United States, Canada, and Sweden KS Ladha, MD Neuman, G Broms, J Bethell, BT Bateman, ... JAMA Network Open 2 (9), e1910734-e1910734, 2019 | 196 | 2019 |
Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium KF Huybrechts, G Bröms, LB Christensen, K Einarsdóttir, A Engeland, ... JAMA psychiatry 75 (2), 167-175, 2018 | 123 | 2018 |
Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden G Bröms, A Haerskjold, F Granath, H Kieler, L Pedersen, IA Berglind Acta dermato-venereologica 98 (8), 728-734, 2018 | 96 | 2018 |
Low risk of birth defects for infants whose mothers are treated with anti–Tumor Necrosis Factor agents during pregnancy G Bröms, F Granath, A Ekbom, K Hellgren, L Pedersen, HT Sørensen, ... Clinical Gastroenterology and Hepatology 14 (2), 234-241. e5, 2016 | 96 | 2016 |
Complications from inflammatory bowel disease during pregnancy and delivery G Bröms, F Granath, M Linder, O Stephansson, M Elmberg, H Kieler Clinical Gastroenterology and Hepatology 10 (11), 1246-1252, 2012 | 96 | 2012 |
Anti‐TNF treatment during pregnancy and birth outcomes: a population‐based study from Denmark, Finland, and Sweden G Bröms, H Kieler, A Ekbom, M Gissler, K Hellgren, ... Pharmacoepidemiology and Drug Safety 29 (3), 316-327, 2020 | 62 | 2020 |
Antidiabetic medication use during pregnancy: an international utilization study CE Cesta, JM Cohen, L Pazzagli, BT Bateman, G Bröms, K Einarsdóttir, ... BMJ Open Diabetes Research and Care 7 (1), e000759, 2019 | 53 | 2019 |
Antipsychotic drug use in pregnancy: a multinational study from ten countries J Reutfors, CE Cesta, JM Cohen, BT Bateman, R Brauer, K Einarsdóttir, ... Schizophrenia research 220, 106-115, 2020 | 49 | 2020 |
Anxiety after coeliac disease diagnosis predicts mucosal healing: a population‐based study JF Ludvigsson, B Lebwohl, Q Chen, G Bröms, RL Wolf, PHR Green, ... Alimentary pharmacology & therapeutics 48 (10), 1091-1098, 2018 | 49 | 2018 |
Preterm birth in women with inflammatory bowel disease–the association with disease activity and drug treatment G Bröms, F Granath, O Stephansson, H Kieler Scandinavian journal of gastroenterology 51 (12), 1462-1469, 2016 | 37 | 2016 |
Paediatric infections in the first 3 years of life after maternal anti‐TNF treatment during pregnancy G Bröms, H Kieler, A Ekbom, M Gissler, K Hellgren, MK Leinonen, ... Alimentary Pharmacology & Therapeutics 52 (5), 843-854, 2020 | 30 | 2020 |
Identification of childhood-onset inflammatory bowel disease in Swedish healthcare registers: a validation study N Mouratidou, P Malmborg, J Järås, V Sigurdsson, O Sandström, ... Clinical epidemiology, 591-600, 2022 | 25 | 2022 |
Perceptions and knowledge of antipsychotics among mental health professionals and patients L Cahling, A Berntsson, G Bröms, L Öhrmalm BJPsych Bulletin 41 (5), 254-259, 2017 | 22 | 2017 |
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study G Bröms, J Söderling, MC Sachs, J Halfvarson, SWIBREG Study Group, ... Scandinavian Journal of Gastroenterology 56 (4), 410-421, 2021 | 12 | 2021 |
Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Netw Open. 2019; 2 (9): e1910734 KS Ladha, MD Neuman, G Broms, J Bethell, BT Bateman, ... | 11 | 2019 |
The patterns of use of medications for inflammatory bowel disease during pregnancy in the US and Sweden are changing G Bröms, S Friedman, SC Kim, ME Wood, S Hernandez-Diaz, G Brill, ... Inflammatory Bowel Diseases 27 (9), 1427-1434, 2021 | 10 | 2021 |
Maternal and infant characteristics: differences and similarities between the Nordic countries and the US L Löfling, G Bröms, S Bahmanyar, H Kieler Clinical epidemiology, 285-294, 2016 | 9 | 2016 |
Increasing healthcare costs in inflammatory bowel disease 2007–2020 in Sweden ÅH Everhov, J Söderling, G Befrits, H Khalili, G Bröms, M Neovius, ... Alimentary pharmacology & therapeutics 58 (7), 692-703, 2023 | 6 | 2023 |
Psychoeducation and motivational interviewing to reduce relapses and increase patients’ involvement in antipsychotic treatment: interventional study G Bröms, L Cahling, A Berntsson, L Öhrmalm BJPsych Bulletin 44 (6), 265-268, 2020 | 6 | 2020 |